Jeffrey Brinker, MD
Family Medicine · Gulf Breeze, FLNPI 1538142484
Payments from drug & device makers
Across 49 payments — averaging $11.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$114
- AstraZeneca$111
- Amgen$73
- Amarin Pharma, Inc.$49
- Pfizer$47
- Lilly USA, LLC$35
- plus $157 from 10 others
What the payments were for
- Food & beverage$58099%
- Education$61%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 12 | $114 |
| AstraZeneca | 10 | $111 |
| Amgen | 5 | $73 |
| Amarin Pharma, Inc. | 4 | $49 |
| Pfizer | 4 | $47 |
| Lilly USA, LLC | 3 | $35 |
| Sanofi-aventis U.S. LLC | 2 | $27 |
| Novartis | 1 | $18 |
| Boehringer Ingelheim | 1 | $18 |
| Astellas Pharma US Inc | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| GSK | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
| Johnson & Johnson | 1 | $11 |
How this compares
$586 in reported general payments places this provider in the 55th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $255 |
| Methylprednisolone | 27 | $170 |
| Doxycycline Hyclate | 20 | $167 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $164 |
| Ciprofloxacin Hcl | 20 | $128 |
| Azithromycin | 15 | $82 |
| Prednisone | 15 | $79 |
| Tramadol Hcl | 31 | $57 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Gulf Breeze
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.